
|**Doubleday Research Fellowship**|**Doubleday Research Fellowship**||**278775**||
|---|---|---|---|---|
|**Receipts andpayments accounts**||||**CC16a**|
|**For the period**<br>**from**|05th April 2026<br>Period start date|**To**|04th April 2026<br>Period end date||



|**Section A Receipts and payments**|**Section A Receipts and payments**|||||
|---|---|---|---|---|---|
|**A1 Receipts**|**Unrestricted**<br>**funds**<br>**to the nearest**<br>**£**<br>**21,341**<br>**409**<br>**21,750**<br>**-**<br>**-**<br>**21,750**<br>**-**<br>**-**<br>**-**<br> **-**<br>**-**<br> **-**<br>**-**<br>**21,750**<br>**-                 4,549**<br>**254**<br>**17,455**|**Restricted**<br>**funds**<br>**to the nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**Endowment**<br>**funds**<br>**to the nearest £**<br>**-**<br>**-**<br>**-**<br>**390,582**<br>**390,582**<br>**390,582**<br>**-**<br>**2,031**<br>**-**<br>**2,031**<br>**384,480**<br>**384,480**<br>**386,511**<br>**4,071**<br>**4,549**<br>**12,524**<br>**21,144**|**Total funds**<br>**to the nearest £**<br>**21,341**<br>**409**<br>**21,750**<br>**390,582**<br>**390,582**<br>**412,332**<br>**-**<br>**2,031**<br>**-**<br>**2,031**<br>**384,480**<br>**384,480**<br>**386,511**<br>**25,821**<br>**-**<br>**12,778**<br>**38,599**|**Last year**<br>**to the nearest £**|
|Income From Investments|**21,341**||||**9,129**|
|Interest Received|**409**||||**9,366**|
|||||||
|**_Sub total_**_(Gross income for_<br>_AR)_|**21,750**||||**18,495**|
|||||||
|**A2 Asset and investment sales,**<br>**(see table).**||||||
|Sale Of Investments|**-**||||**732,175**|
|||||||
|**_Sub total_**|**-**||||**732,175**|
|**_Total receipts_**<br>**A3 Payments**||||||
||||||**750,670**|
|||||||
|Grants Awarded|**-**||||**17,790**|
|Investment Manager Fees|**-**||||**959**|
|Trust Administration Fees|**-**||||**3,601**|
|||||||
|||||||
|||||||
|**_Sub total_ **|**-**||||**22,349**|
|||||||
|**A4 Asset and investment**<br>**purchases, (see table)**||||||
|Investment Purchases|**-**||||**718,474**|
|||||||
|**_Sub total_ **|**-**||||**718,474**|
|**_Total payments_**<br>**_Net of receipts/(payments)_**<br>**A5 Transfers between funds**<br>**A6 Cash funds last year end**<br>**_Cash funds this year end_**||||||
||||||**740,823**|
|||||||
||**21,750**|**-**|**4,071**|**25,821**|**9,846**|
||**-                 4,549**||**4,549**|**-**|**-**|
||**254**||**12,524**|**12,778**|**2,931**|
||**17,455**|**-**|**21,144**|**38,599**|**12,778**|



CCXX R1 accounts (SS) 

1 



|**Section B Statement of assets and liabilities at the end of the period**|**Section B Statement of assets and liabilities at the end of the period**|**Section B Statement of assets and liabilities at the end of the period**||
|---|---|---|---|
|**Categories**<br>Signed by one or two trustees on<br>behalf of all the trustees<br>**B1 Cash funds**<br>**B2 Other monetary assets**<br>**B4 Assets retained for the**<br>**charity’s own use**<br>**B5 Liabilities**<br>**B3 Investment assets**|Signature<br>Capital Account<br>Income Account<br>**Details**<br>**_Total cash funds_**<br>(agree balances with receipts and payments<br>account(s))<br>**Details**<br>**Details**<br>Investment Portfolio<br>**Details**<br>**Details**|**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**to nearest £**<br>**to nearest £**<br>**-**<br>**-**<br>**17,455**<br>**-**<br>**17,455**<br>**-**<br>OK<br>OK<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**to nearest £**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**asset belongs**<br>**Cost (optional)**<br>**Endowment**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**asset belongs**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**liability relates**<br>**Amount due**<br>**(optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>Print Name<br>Marta Kurpickaja on behalf of Ludlow<br>Trust Company (Southampton)Limited|**Endowment**<br>**funds**<br>**to nearest £**|
||||**21,144**|
||||**-**|
|||||
||||**21,144**|
||||OK|
||||**Endowment**<br>**funds**<br>**to nearest £**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**938,652**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**When due**<br>**(optional)**|
|||||
|||||
|||||
|||||
|||||
|||||
||||Date of<br>approval|
|||Marta Kurpickaja on behalf of Ludlow<br>Trust Company (Southampton)Limited||
||||04/09/2026|



CCXX R2 accounts (SS) 

2 




## **Trustees’ Annual Report for the period** 

## **From 5 April 2025 To 4 April 2026** 

## **Charity name: Doubleday Research Fellowship Charity registration number: 278775** 

## **Objectives and Activities** 

||SORP reference||
|---|---|---|
|Summary of the purposes of<br>the charity as set out in its<br>governing document|Para 1.17|To hold the capital and income upon trust to<br>apply the income and all or such parts of the<br>capital at such time or times and in such a<br>manner to or for the benefit of a research<br>fellowship in dental surgery and allied<br>subjects at the dental school of Guy’s<br>hospital.|
|Summary of the main<br>activities in relation to those<br>purposes for the public<br>benefit, in particular, the<br>activities, projects or<br>services identified in the<br>accounts.|Para 1.17 and<br>1.19|In furtherance of the charity’s objects for the<br>public benefit the trustees provide grants.|
|Statement confirming<br>whether the trustees have<br>had regard to the guidance<br>issued by the Charity<br>Commission on public<br>benefit|Para 1.18|In determining the charity’s activities, the<br>trustees have had regard to the Charity<br>Commission’s guidance on public benefit.|





## **Additional information (optional)** You may choose to include further statements where relevant about: 

||SORP reference||
|---|---|---|
|Policy on grant making|Para 1.38||
|Policy on social investment<br>including program related<br>investment|Para 1.38||
|Contribution made by<br>volunteers|Para 1.38||
|Other|||



## **Achievements and Performance** 

||SORP reference||
|---|---|---|
|Summary of the main<br>achievements of the charity,<br>identifying the difference the<br>charity’s work has made to<br>the circumstances of its<br>beneficiaries and any wider<br>benefits to society as a<br>whole.|Para 1.20|During the year under review the charity<br>awarded no grants.|





|**Additional information (optional)**<br>You may choose to include further statements where relevant about:|**Additional information (optional)**<br>You may choose to include further statements where relevant about:|**Additional information (optional)**<br>You may choose to include further statements where relevant about:|
|---|---|---|
|Achievements against<br>objectives set|Para 1.41||
|Performance of fundraising<br>activities against objectives<br>set|Para 1.41||
|Investment performance<br>against objectives|Para 1.41||
|Other|||



## **Financial Review** 

|Review of the charity’s<br>financial position at the end<br>of the period|Para 1.21|At the end of the reporting period the charity<br>had free reserves of £17,455 (2025: £254).<br>In addition to the free reserves the charity<br>has bank balances of £21,144 (2025:<br>£12,524)<br>and<br>investments<br>valued<br>at<br>£938,652 within the expendable endowment<br>fund which can be released to support the<br>activities of the charity.|
|---|---|---|
|Statement explaining the<br>policy for holding reserves<br>stating why they are held|Para 1.22|The Trustees pursue a policy of maintaining<br>a free reserve available to be spent in the<br>furtherance of the charity’s objectives as<br>well as covering future needs, opportunities,<br>contingencies and risks.|
|Amount of reserves held|Para 1.22||
|Reasons for holding zero<br>reserves|Para 1.22||
|Details of fund materially in<br>deficit|Para 1.24||
|Explanation of any<br>uncertainties about the<br>charity continuing as a going<br>concern|Para 1.23||





|**Additional information (optional)**<br>You may choose to include further statements where relevant about:|**Additional information (optional)**<br>You may choose to include further statements where relevant about:|**Additional information (optional)**<br>You may choose to include further statements where relevant about:|
|---|---|---|
|The charity’s principal<br>sources of funds (including<br>any fundraising)|Para 1.47||
|Investment policy and<br>objectives including any<br>social investment policy<br>adopted|Para 1.46||
|A description of the principal<br>risks facing the charity|Para 1.46||
|Other||Expendable endowment funds are those<br>which are required to be invested to produce<br>income, but which may be transferred to<br>unrestricted funds at the discretion of the<br>trustees in order that they may be expended<br>in furtherance of the charity’s objectives.<br>Unrestricted income funds are available for<br>use at the discretion of the trustees in<br>furtherance of the general objectives of the<br>charity and which have not been designated<br>for other purposes.|





## **Structure, Governance and Management** 

|Description of charity trusts:|||
|---|---|---|
|Type of governing document|Para 1.25|Will dated: 18 August 1967<br>Date of Death: 4 April 1971<br>Will Proved at Probate 22 August 1979<br>Date registered: 11 January1980|
|How is the charity<br>constituted?|Para 1.25|Trust|
|Trustee selection methods<br>including details of any<br>constitutional provisions e.g.<br>election to post or name of<br>any person or body entitled<br>to appoint one or more<br>trustees|Para 1.25|Trustees are appointed by the existing<br>trustees.|



|**Additional information (optional)**<br>You may choose to include further statements where relevant about:|**Additional information (optional)**<br>You may choose to include further statements where relevant about:|**Additional information (optional)**<br>You may choose to include further statements where relevant about:|
|---|---|---|
|Policies and procedures<br>adopted for the induction<br>and training of trustees|Para 1.51||
|The charity’s organisational<br>structure and any wider<br>network with which the<br>charity works|Para 1.51||
|Relationship with any related<br>parties|Para 1.51|No trustee received any remuneration or<br>was reimbursed for any expenses in the<br>year under review.<br>Ludlow Trust Company (Southampton)<br>Limited was paid £Nil (2025: £3,601) for<br>trust administration fees during the year<br>under review.  These fees are authorised<br>under clause 3 of the trust deed.|
|Other|||





## **Reference and Administrative details** 

|Charity name|Doubleday Research Fellowship|
|---|---|
|Other name the charity uses||
|Registered charity number|278775|
|Charity’s principal address|Ludlow Trust Company (Southampton) Limited, Yarmouth<br>House, 1300 Parkway, Solent Business Park, Whiteley,<br>PO15 7AX|
|||



## **Names of the charity trustees who manage the charity** 

|1|**Trustee name**|**Office (if**<br>**any)**|**Dates acted if not for whole**<br>**year**|**Name of person (or**<br>**body) entitled to**<br>**appoint trustee (if**<br>**any)**|
|---|---|---|---|---|
||Ludlow Trust<br>Company<br>(Southampton)<br>Limited||||
||||||
||||||
||||||



– Corporate trustees names of the directors at the date the report was approved 

|**Director name**|||
|---|---|---|
|Walter Duncan Coxon|||
|Alexander Edward Mulroe|Appointed 01 April 2026||
|Christopher Ian Thurlow|||
|Matthew John Wickers|||
|Gary St John Collins|Resigned 31 March 2026||
||||
||||



Name of trustees holding title to property belonging to the charity 

**Trustee name Dates acted if not for whole year** 



## **Funds held as custodian trustees on behalf of others** 

Description of the assets held in this capacity Name and objects of the charity on whose behalf the assets are held and how this falls within the custodian charity’s objects Details of arrangements for safe custody and segregation of such assets from the charity’s own assets 

## **Additional information (optional)** 

## **Names and addresses of advisers (Optional information)** 

|**Type of adviser**|**Name**<br>**Address**|**Name**<br>**Address**|
|---|---|---|
|**Investment Managers**|HSBC Uk Bank Plc|1 Centenary Square, Birmingham, B1<br>1HQ|
|**Bankers**|HSBC Uk Bank Plc|1 Centenary Square, Birmingham, B1<br>1HQ|
|**Accountants**|Charter Tax Consulting<br>Limited|8th Floor, 1 Southampton Street, London<br>WC2R 0LR|
||||



## **Name of chief executive or names of senior staff members (Optional information)** 



## **Exemptions from disclosure** 

Reason for non-disclosure of key personnel details 

## **Other optional information** 

## **Declarations** 

**The trustees declare that they have approved the trustees’ report above.** 

**Signed on behalf of the charity’s trustees** 

|**Signature(s)**<br>**Full name(s)**<br>**Position (e.g. Secretary,**<br>**Chair, etc.)**<br>**Date**||||
|---|---|---|---|
||Marta Kurpickaja on behalf of<br>Ludlow Trust Company<br>(Southampton) Limited|||
||<br>Trustee|||
||<br>04/09/2026|||
||<br>04/09/2026|||





## Doubleday Research Fellowship Accounts to 

## sign 

## Final Audit Report 2026-09-04 

Created: 2026-09-04 By: Rytis Mendelis (rytis.mendelis@ludlowtrust.com) Status: Signed Transaction ID: CBJCHBCAABAAmSIlzevQmVRsxqIDU7PEa14zeejxnUVd 

## "Doubleday Research Fellowship Accounts to sign" History 

Document created by Rytis Mendelis (rytis.mendelis@ludlowtrust.com) 

2026-09-04 - 9:53:47 AM GMT 

Document emailed to Marta Kurpickaja (marta.kurpickaja@ludlowtrust.com) for signature 2026-09-04 - 9:53:53 AM GMT 

Email viewed by Marta Kurpickaja (marta.kurpickaja@ludlowtrust.com) 

2026-09-04 - 10:08:10 AM GMT 

Document e-signed by Marta Kurpickaja (marta.kurpickaja@ludlowtrust.com) 

Signature Date: 2026-09-04 - 10:08:57 AM GMT - Time Source: server - Signature Appearance Selected: IMAGE 

## Agreement completed. 

2026-09-04 - 10:08:57 AM GMT 

